Home  |   Archive  |   Online Submission  |   News & Events  |   Subscribe  |   APFA  |   Society  |   Contact Us  |   中文版
Search   
 
Journal

Ahead of print
Authors' Accepted
    Manuscripts
new!
Current Issue
Archive
Acknowledgments
Special Issues
Browse by Category

Manuscript Submission

Online Submission
Online Review
Instruction for Authors
Instruction for Reviewers
English Corner new!

About AJA

About AJA
Editorial Board
Contact Us
News

Resources & Services

Advertisement
Subscription
Email alert
Proceedings
Reprints

Download area

Copyright licence
EndNote style file
Manuscript word template
Guidance for AJA figures
    preparation (in English)

Guidance for AJA figures
    preparation (in Chinese)

Proof-reading for the
    authors

AJA Club (in English)
AJA Club (in Chinese)

 
中文摘要

《亚洲男性学杂志》 2011; 13 (6): 833-837

《亚洲男性学杂志》 2011; 13 (6): 833-837

经双睾丸切除术的雄激素剥夺疗法:使代谢紊乱风险升高

Juan-Jie Bo, Chao Zhang, Lian-Hua Zhang, Ping Liu, Jian-Jun Sha, Jian-Wei Lv, Dong-Ming Liu, Yi-Ran Huang and Zheng Li (中国)

前列腺癌是男性最常见的恶性肿瘤之一,对于转移性或复发性肿瘤,内分泌治疗是重要的治疗手段,且可能对局部进展性肿瘤有益。既往研究显示内分泌治疗可能伴随代谢指标的改变。本研究共纳入133 名研究对象,其中包括46 名接受双睾丸切除术的患者(内分泌治疗组);37 名接受前列腺癌根治术的患者(非内分泌治疗组)以及50 名正常男性(对照组),所有研究对象均随访12 个月以上。治疗3个月后,内分泌治疗组血清胰岛素和低密度脂蛋白明显升高(P<0.05); 12 个月后,内分泌治疗组腰围、血清胰岛素、血糖、总胆固醇、高密度脂蛋白和低密度脂蛋白较其他两组升高(P<0.05 ),且代谢综合征发病率较高(P<0.05 )。前列腺癌内分泌治疗可能导致代谢紊乱风险的升高,使用内分泌治疗前需谨慎地评估利弊。

关键词:内分泌治疗,双睾切除,代谢改变,代谢综合征,前列腺癌

此摘要文献来源:
Juan-Jie Bo, Chao Zhang, Lian-Hua Zhang, Ping Liu, Jian-Jun Sha, Jian-Wei Lv, Dong-Ming Liu, Yi-Ran Huang and Zheng Li. Androgen deprivation therapy through bilateral orchiectomy: increased metabolic risks. Asian Journal of Andrology 2011; 13: 833-837

 
Asian Journal of Andrology CN 31-1795/R ISSN 1008-682X  Copyright © 2023  Shanghai Materia Medica, Chinese Academy of Sciences.  All rights reserved.